Broomfield, Colorado-based MicroBiome Therapeutics reported this morning that it has raised $1.3M in a bridge financing round, to go towards its clinical studies. The funding came from BVM Capital, a current investor in the company, along with its other investors. MicroBiome said the funds will go towards clinical trials of its lead product, which is aimed at treating type 2 diabetes and prediabetes. Microbiome is led by Steve Orndorff.
Top NewsMonday, December 16, 2013
MicroBiome Therapeutics Gets $1.3M